370 related articles for article (PubMed ID: 27355628)
1. Temporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia.
Mowlaboccus S; Perkins TT; Smith H; Sloots T; Tozer S; Prempeh LJ; Tay CY; Peters F; Speers D; Keil AD; Kahler CM
PLoS One; 2016; 11(6):e0158315. PubMed ID: 27355628
[TBL] [Abstract][Full Text] [Related]
2. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
[No Abstract] [Full Text] [Related]
3. Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation.
Brehony C; Rodrigues CMC; Borrow R; Smith A; Cunney R; Moxon ER; Maiden MCJ
Vaccine; 2016 Sep; 34(39):4690-4697. PubMed ID: 27521232
[TBL] [Abstract][Full Text] [Related]
4. Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020.
Muzzi A; Lu M-C; Mori E; Biolchi A; Fu T; Serino L
mSphere; 2024 Jun; 9(6):e0022024. PubMed ID: 38752729
[No Abstract] [Full Text] [Related]
5. Characterization of invasive meningococcal disease case isolates in Atlantic Canada, 2014 to 2020: spatial-temporal variations of clones and predicted meningococcal B vaccine coverage.
Tsang RSW; Law DKS; Zhou J; Haldane D; Garceau R; Zahariadis G; Mead K; Alexander D
J Med Microbiol; 2022 Dec; 71(12):. PubMed ID: 36748536
[No Abstract] [Full Text] [Related]
6. Strain coverage of Bexsero vaccine assessed by whole-genome sequencing over a cohort of invasive meningococci of serogroups B and W isolated in Switzerland.
Leo S; Lazarevic V; Girard M; Getaz-Jimenez Velasco GC; Gaïa N; Renzi G; Cherkaoui A; Hong E; Taha MK; Schrenzel J
Vaccine; 2020 Jul; 38(33):5324-5331. PubMed ID: 32561121
[TBL] [Abstract][Full Text] [Related]
7. Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland.
Bodini M; Brozzi A; Giuliani M; Nohynek H; Vainio A; Kuusi M; De Paola R; Pizza M; Medini D; Toropainen M; Serino L; Muzzi A
mSphere; 2020 Sep; 5(5):. PubMed ID: 32938694
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage.
Frosi G; Biolchi A; Lo Sapio M; Rigat F; Gilchrist S; Lucidarme J; Findlow J; Borrow R; Pizza M; Giuliani MM; Medini D
Vaccine; 2013 Oct; 31(43):4968-74. PubMed ID: 23954380
[TBL] [Abstract][Full Text] [Related]
9. Characterization of invasive Neisseria meningitidis isolates recovered from children in Turkey during a period of increased serogroup B disease, 2013-2017.
Ceyhan M; Ozsurekci Y; Lucidarme J; Borrow R;
Vaccine; 2020 Apr; 38(19):3545-3552. PubMed ID: 32199701
[TBL] [Abstract][Full Text] [Related]
10. Genetic variability of Polish serogroup B meningococci (2010-2016) including the 4CMenB vaccine component genes.
Waśko I; Gołębiewska A; Kiedrowska M; Ronkiewicz P; Wróbel-Pawelczyk I; Kuch A; Hong E; Skoczyńska A
Vaccine; 2020 Feb; 38(8):1943-1952. PubMed ID: 31980191
[TBL] [Abstract][Full Text] [Related]
11. High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007-2011: Concordant predictions between MATS and genetic MATS.
Tozer SJ; Smith HV; Whiley DM; Borrow R; Boccadifuoco G; Medini D; Serruto D; Giuliani MM; Stella M; De Paola R; Muzzi A; Pizza M; Sloots TP; Nissen MD
Hum Vaccin Immunother; 2021 Sep; 17(9):3230-3238. PubMed ID: 33847225
[TBL] [Abstract][Full Text] [Related]
12. High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland.
Waśko I; Hong E; De Paola R; Stella M; Moschioni M; Taha MK; Skoczyńska A
Vaccine; 2016 Jan; 34(4):510-515. PubMed ID: 26686998
[TBL] [Abstract][Full Text] [Related]
13. Predicted coverage by 4CMenB vaccine against invasive meningococcal disease cases in the Netherlands.
Freudenburg-de Graaf W; Knol MJ; van der Ende A
Vaccine; 2020 Nov; 38(49):7850-7857. PubMed ID: 33097311
[TBL] [Abstract][Full Text] [Related]
14. Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B
Tsang RSW; Law DKS; De Paola R; Giuliani M; Stella M; Zhou J; Deng S; Boccadifuoco G; Giuliani MM; Serino L
mSphere; 2020 Mar; 5(2):. PubMed ID: 32132156
[TBL] [Abstract][Full Text] [Related]
15. Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia.
Mowlaboccus S; Mullally CA; Richmond PC; Howden BP; Stevens K; Speers DJ; Keil AD; Bjørnstad ON; Perkins TT; Kahler CM
PLoS One; 2017; 12(10):e0186839. PubMed ID: 29065137
[TBL] [Abstract][Full Text] [Related]
16. Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020).
Honskus M; Krizova P; Okonji Z; Musilek M; Kozakova J
PLoS One; 2023; 18(3):e0282971. PubMed ID: 36913385
[TBL] [Abstract][Full Text] [Related]
17. Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak?
Lucidarme J; Lekshmi A; Parikh SR; Bray JE; Hill DM; Bratcher HB; Gray SJ; Carr AD; Jolley KA; Findlow J; Campbell H; Ladhani SN; Ramsay ME; Maiden MCJ; Borrow R
J Infect; 2017 Aug; 75(2):95-103. PubMed ID: 28579305
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of a collection of Neisseria meningitidis isolates from Croatia, June 2009 to January 2014.
Bukovski S; Vacca P; Anselmo A; Knezovic I; Fazio C; Neri A; Ciammaruconi A; Fortunato A; Palozzi AM; Fillo S; Lista F; Stefanelli P
J Med Microbiol; 2016 Sep; 65(9):1013-1019. PubMed ID: 27452726
[TBL] [Abstract][Full Text] [Related]
19. Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022.
Rodrigues CMC; MacDonald L; Ure R; Smith A; Cameron JC; Maiden MCJ
mBio; 2023 Apr; 14(2):e0049923. PubMed ID: 37036356
[TBL] [Abstract][Full Text] [Related]
20. Genomic surveillance of Neisseria meningitidis serogroup B invasive strains: Diversity of vaccine antigen types, Brazil, 2016-2018.
de Lemos APS; Sacchi CT; Gonçalves CR; Camargo CH; Andrade AL
PLoS One; 2020; 15(12):e0243375. PubMed ID: 33347452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
